ArticleScientific reports2026
Modeling and experimental verification of polycaprolactone nanoparticle precipitation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Synthesis,ACS omega · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A numerical model based on the diffusion equation was developed to predict the size of polycaprolactone (PCL) nanoparticles produced via nanoprecipitation. The model requires minimal input data, making it cost-effective and experimentally efficient. It accounts for both diffusion-driven growth and the finite coalescence time of particles, a factor often overlooked in nanoparticle formation. Nanoparticles were synthesized under controlled variation of polymer concentration, surfactant amount, and mixing method, including microfluidics. The model demonstrated strong agreement with experimental data, yielding higher predictive accuracy than prior diffusion-limited models. It also enabled optimization of process parameters, improving control over size distribution and reducing aggregation. The proposed framework enhances nanoprecipitation scalability and reproducibility while lowering resource consumption. Its modular structure allows adaptation to other polymers and formulation conditions. This approach offers a practical and computationally efficient tool for the rational design of polymeric nanoparticles, with broad relevance to biomedical applications, including targeted drug delivery and nanomedicine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.